111, Inc. (YI)
NASDAQ: YI · IEX Real-Time Price · USD
1.045
-0.015 (-1.42%)
At close: Jul 2, 2024, 3:59 PM
1.050
+0.005 (0.48%)
After-hours: Jul 2, 2024, 7:00 PM EDT
111, Inc. Revenue
111, Inc. had revenue of $2.05B in the twelve months ending March 31, 2024, down -0.90% year-over-year. Revenue in the quarter ending March 31, 2024 was $490.06M, a -8.93% decrease year-over-year. In the year 2023, 111, Inc. had annual revenue of $2.11B with 8.72% growth.
Revenue (ttm)
$2.05B
Revenue Growth
-0.90%
P/S Ratio
0.04
Revenue / Employee
$1,350,493
Employees
1,520
Market Cap
89.47M USD
Revenue Chart
* The company reports in CNY currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.11B | 169.07M | 8.72% |
Dec 31, 2022 | 1.94B | -2.28M | -0.12% |
Dec 31, 2021 | 1.94B | 687.24M | 54.79% |
Dec 31, 2020 | 1.25B | 689.73M | 122.17% |
Dec 31, 2019 | 564.58M | 306.12M | 118.44% |
Dec 31, 2018 | 258.46M | 113.43M | 78.21% |
Dec 31, 2017 | 145.03M | 18.39M | 14.52% |
Dec 31, 2016 | 126.64M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Well | 254.57M |
CytomX Therapeutics | 119.18M |
InterCure | 97.95M |
Elutia | 28.99M |
Myomo | 19.55M |
BeyondSpring | 1.75M |
VistaGen Therapeutics | 1.06M |
YI News
- 21 days ago - 111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility - PRNewsWire
- 5 weeks ago - 111, Inc. Announces First Quarter 2024 Unaudited Financial Results - PRNewsWire
- 2 months ago - 111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow - PRNewsWire
- 3 months ago - 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results - PRNewsWire
- 4 months ago - 111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow - PRNewsWire
- 4 months ago - 111 Announces Receipt of Withdrawal of Going Private Proposal - PRNewsWire
- 6 months ago - Top 4 Defensive Stocks That Could Lead To Your Biggest Gains This Quarter - AgriFORCE Growing Systems (NASDAQ:AGRI), Maison Solutions (NASDAQ:MSS) - Benzinga
- 7 months ago - 111, Inc. Announces Third Quarter 2023 Unaudited Financial Results - PRNewsWire